Clinical Trial

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

Study acronym: PERSIST
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms.
Trial Details
NCT Number NCT07474051
Lead Sponsor AvenCell Therapeutics, Inc.
Collaborators: AvenCell Europe GmbH
Conditions B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hematologic Malignancy, AML (Acute Myelogenous Leukemia), Prostate Cancer
Enrollment 178 participants
Start Date 2026-01-29
Primary Completion 2040-11-30 (estimated)
Study Completion 2041-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-16